ARCHIVES

Proflavine Bioassay Ineffective, NCI Says

This article is from The Cancer Letter archive.

Vol. 03 No. 28 | July 15, 1977

Download PDF Visit The Full Archive

Related Articles

NCI Issues Alert On Stage 2/3 Rectal Cancer Therapy

March 22, 1991

NCI Advisors To Gain Increased Responsibility For Concept, Technical Merit Review Of Contracts

December 19, 1980

FCRF Recompetition Notice Of Intent

September 19, 1980

Second Irregularity In NSABP Data Found; Fisher Takes Leave As Group’s Chairman

April 1, 1994

St. Jude, Washington University Plan $65 Million Pediatric Cancer Genome Project

January 29, 2010

Stovall To Step Down As NCCS President At End Of 2008.

September 21, 2007